v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income (loss) for the period $ (17,306,445) $ (3,512,156)
Adjustments to reconcile net loss to cash for operating activities    
Depreciation and amortization 8,519 27,085
Accretion of debt discount and issuance cost 1,727,449 48,775
Stock based compensation 12,748,152 3,310,183
Unrealized gain on marketable securities 1,261,526 (36,461)
Change in fair value of derivative liability (639,644) 0
Loss from discontinued operations 466,499 0
Loss on disposal of discontinued operations 912,840 0
Gain on extinguishment of debt 0 (9,238)
Amortization of right of use asset 417 22,277
Amortization of discount on note receivable (127,604) 0
Gain on settlement of liabilities (948,031) (518,115)
Changes in operating assets and liabilities (net of acquired amounts):    
Accounts receivable (21,250) (41,125)
Prepaid expenses and other current assets 102,793 (2,000)
Deposits and other assets 0 29,053
Accounts payable and accrued liabilities (516,125) 32,158
Deferred revenue (33,624) (29,257)
Net cash used in operating activities (2,364,528) (678,821)
Cash flows from investing activities:    
Cash received from sale of interest in Flyte, Inc. 0 100,000
Purchases of marketable securities (19,636) 0
Proceeds from sales of marketable securities 79,170 0
Cash received in consideration for disposal of business, net of cash divested 993,332 0
Purchases of property and equipment (176,343) 0
Collections on note receivable 1,500,000 0
Net cash provided by investing activities 2,376,523 100,000
Cash flows from financing activities:    
Proceeds from issuance of notes payable and warrants 164,500 153,054
Proceeds from issuance of convertible notes 300,000 0
Proceeds from issuance of preferred stock 0 1,231,000
Proceeds from issuance of common stock 0 278,138
Repayment of notes payable (177,064) (84,457)
Repayment of convertible notes 0 (10,760)
Purchase of noncontrolling interest (185,691) 0
Principal payments on finance lease liabilities (379) 0
Net cash provided by financing activities 101,366 1,566,975
Effect of exchange rate changes on cash 0 (358)
Net increase in cash and cash equivalents 113,361 987,796
Cash and cash equivalents at beginning of period 221,742 15,490
Cash and cash equivalents at end of period 335,103 1,003,286
Supplemental disclosure of cash flow information:    
Cash paid for interest 39,821 20,097
Cash paid for income taxes 0 0
Supplemental disclosure of non-cash investing and financing activities:    
Stock issued for acqusition of business 0 14,072,253
Goodwill recognized in acquisition of business 0 8,087,902
Intangible assets recognized in acqusition of business 0 7,821,867
Shares issued with debt 0 2,122
Warrants issued with debt 0 12,046
Stock paid for marketable securities 0 16,257
Stock paid for minority investments 0 839,500
Non-cash settlement of liabilities 0 9,198
Deemed dividend 384,700 1,363,254
Preferred stock receivable in consideration for disposal of business 5,614,086 0
Promissory Note Receivable issued in consideration for disposal of business 4,787,469 0
Liabilities assumed as consideration for disposal of business 239,446 0
Debt discount recorded on issuance of convertible note from equity classified warrants 238,170 0
Day 1 bifurcation of embedded derivative on convertible note 61,830 0
Right-of-use assets obtained in exchange for new finance lease liabilities $ 10,012 $ 0